CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
South Korea · Delayed Price · Currency is KRW 1,122.00
+22.00 (2.00%)
Jun 12, 2026, 3:30 PM KST
CMG Pharmaceutical Revenue
CMG Pharmaceutical had revenue of 25.52B KRW in the quarter ending March 31, 2026, with 23.71% growth. This brings the company's revenue in the last twelve months to 110.12B, up 13.63% year-over-year. In the year 2025, CMG Pharmaceutical had annual revenue of 105.23B with 6.19% growth.
Revenue (ttm)
110.12B
Revenue Growth
+13.63%
P/S Ratio
1.51
Revenue / Employee
493.81M
Employees
223
Market Cap
165.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 105.23B | 6.13B | 6.19% |
| Dec 31, 2024 | 99.10B | 5.19B | 5.53% |
| Dec 31, 2023 | 93.91B | 11.71B | 14.25% |
| Dec 31, 2022 | 82.20B | 23.57B | 40.21% |
| Dec 31, 2019 | 58.62B | 8.76B | 17.56% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jeil Pharmaceutical Co.,Ltd | 534.52B |
| Dongwha Pharm.Co.,Ltd | 501.33B |
| Ilyang Pharmaceutical Co.,Ltd | 275.51B |
| Whan In Pharm | 266.19B |
| JW Lifescience | 252.72B |
| HLB Pharmaceutical | 236.59B |
| Daihan Pharmaceutical | 211.44B |
| Samil Pharmaceutical Co.,Ltd | 210.51B |